Should we treat subclinical hyperthyroidism?
Franklyn
Jayne A
JA
Institute ofBiomedical Research, Medical School, University of Birmingham, Edgbaston, Birmingham, UK. j.a.franklyn@bham.ac.uk
D003937:Diagnosis, Differential; D004198:Disease Susceptibility / Q000097:blood / Q000175:diagnosis / Q000628:therapy*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000097:blood / Q000175:diagnosis / Q000473:pathology*; D018447:Medical Futility; D013963:Thyroid Hormones / Q000097:blood; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000008:administration & dosage
D013963:Thyroid Hormones; D013972:Thyrotropin; D013974:Thyroxine